By employing HF-fed HEPiPLA2γKO mice, we demonstrated that genetic ablation of hepatic iPLA2γ improved glucose tolerance and decreased production of detrimental oxidized arachidonate metabolites resulting in a decrease in Ca2+-induced mPTP opening. This evidence concerns the gene PNPLA8 and hydrops fetalis.